Bladder cancer is the 10th most common cancer type worldwide. Cystoscopy represents the
gold standard for bladder cancer diagnosis, but this procedure is invasive and painful …

Bladder cancer (BC) has high morbidity and mortality rates owing to challenges in clinical
diagnosis and treatment. Advanced BC is prone to recurrence after surgery, necessitating …

The non-muscle invasive bladder cancer tends to recur and progress. Therefore, it requires
frequent follow-ups, generating costs and making it one of the most expensive neoplasms …

Background: Artificial intelligence has the potential to innovate current practices used to
detect the imminent risk of suicide and to address shortcomings in traditional assessment …

Simple Summary In the present study, we aimed to construct a methylation diagnostic tool
using urine sediment for the detection of urothelial bladder carcinoma (UBC), and improved …

Urine‐based liquid biopsy has emerged as a non‐invasive and effective tool for early
screening and diagnosis of bladder cancer. This review provides a comprehensive overview …

Simple Summary Due to the high heterogeneity and variability of bladder cancer, the
identification of new biomarkers involved in the development and mechanisms of tumor …

Nanorobotics: consultant starting 5/21. C2I genomics: consultant starting 10/20. Photocure:
consultant/advisor, scientific study or trial. Astra-Zeneca: consultant/advisor. Merck …

Bladder cancer (BLCA) is one of the most common types of malignant tumors of the
urogenital system in adults. Globally, the incidence of BLCA is more than 500,000 new …

High cancer mortality rates and the rising cancer burden worldwide drive the development of
innovative methods in order to advance cancer diagnostics. Urine contains a viable source …